2025 Impact Report: A Record-Breaking Year for the Pelotonia Community

The Pelotonia community raised $29.2 million for cancer research, contributing to a total of $339 million since 2009.

More than 12,000 individuals participated — through our signature events, Ride Weekend and Gravel Day, or as Challengers.

7,249 Riders and 352 Runners/Hikers rallied together.

980 cancer Survivors joined the mission — an all-time record.

A record 800 High Rollers — our top fundraisers — participated.

3,173 Volunteers served 17,866 hours.

Participants came from 12 countries and across 49 U.S. states (all except Alaska).

11 Pelotonia Kids rides raised more than $167,000 for pediatric cancer research.

The community rallied around the annual theme, Together as One.

We celebrated nine incredible individuals and one inspiring community with the Pelotonia Awards.

The Pelotonia Legacy Society includes passionate community members committed to long-term impact through planned giving.

Stories of innovative initiatives from Huntington Bank, Victoria's Secret, M/I Homes, RTRX, and Pelotonia Roundtable, inspire creative ways to increase impact.

Ohio State has recruited 300+ top cancer scientists with Pelotonia support.

Four individual spotlights feature a few of these bright talented, recruits — plus Dr. Glen Barber, recruited in 2024 was named to Citation Laureate for Nobel-class research.

7 new Pelotonia Idea Grants worth $1.8 million were awarded to support cutting-edge, early stage research.

A paradigm-shifting study, led by PIIO Director Dr. Zihai Li and funded by an Idea Grant, learns why the body's immune system T cells can fail, launching a new approach to immunotherapy treatment.

An Idea Grant is helping uncover contributions to non-small cell lung cancer and possible new treatments for this deadly disease.

Pelotonia funding supports statewide initiatives that promote early detection and better outcomes for colorectal, uterine, lung, and breast cancer in Ohio.

Beating Lung Cancer in Ohio has enrolled nearly 500 patients across 68 of Ohio's 88 counties. Research findings are informing care nationally.

An update on progress of the first drug fully developed at Ohio State for treating patients with solid tumors or non-Hodgkin lymphoma shares that it is expanding and will soon also be offered in a clinical trial for acute myeloid leukemia (AML).

Pelotonia funding supports the Clinical Trials Office, and there are 650+ clinical trials available at the OSUCCC – James.

More than $2.5 million for 22 scholarships were awarded for Pelotonia Scholars across various disciplines and levels.

734 Pelotonia Scholars from 53 countries and 36 U.S. states have been funded since 2010.

Scholars spotlights in this report feature research impacting chronic lymphocytic leukemia (CLL), cancer genetics, and urothelial carcinoma, the most common type of bladder cancer.

A new first-in-human clinical trial for glioblastoma offers hope for patients with this aggressive form of brain cancer in a study led by investigators at the PIIO.

The first-of-its-kind, nationwide decentralized clinical trial conducted entirely by telehealth launched with support from an Idea Grant, led by Dr. Sameek Roychowdhury.